SteQeyma ™ 45mg and 90mg solution for injection via autoinjector (pre-filled pen) receives positive CHMP opinion, which will facilitate subcutaneous administration in patients with plaque psoriasis, ...
Phase 3 study met all primary and secondary endpoints, demonstrating superior convenience, strong efficacy, and excellent safety versus conventional ondansetron injections RAICHUR, India, Nov. 11, ...
This Phase 3 clinical trial on BioChaperone® Lispro (THDB0206 injection) conducted in China in people with Type 1 Diabetes, successfully demonstrated, in comparison with standard of care Humalog®: Non ...
Mykhailo Mudryk is currently fighting against a 4-year ban from football, but he’s facing a rather uphill battle after testing positive (both samples) last season for a banned substance. He’s not ...
The Athletic has live coverage of the U.S. Open men’s final featuring Jannik Sinner vs. Carlos Alcaraz Editor’s note: This story is part of Peak, The Athletic’s desk covering leadership, personal ...
SPX FLOW’s APV brand introduces the APV DW+ Positive Displacement Pump, the next generation of its DW Series. Designed to optimize the processing of high-value, high-viscosity products, the DW+ pump ...
The positive displacement pumps market is expected to generate approximately USD 15.3 billion in revenue by 2025 and is projected to reach nearly USD 22.9 billion by 2035. This reflects a steady ...
SAN DIEGO, April 28, 2025 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) (Halozyme) today announced that argenx received a positive opinion from the Committee for Medicinal Products for ...
Merck (MRK) released phase III data for an injection form of its blockbuster cancer treatment drug Keytruda and announced the FDA is reviewing the application for approval. The data showed that when ...
The PP353 clinical trial met the primary endpoint and demonstrated statistically significant, clinically meaningful and durable reduction in pain and disability in patients with chronic Low Back Pain ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results